|
ZNF845 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.558900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.872600E-01 |
| Normal-vs-Stage2 |
4.366400E-02 |
| Normal-vs-Stage3 |
3.67720000000737E-05 |
| Normal-vs-Stage4 |
4.27029999999773E-05 |
| Stage1-vs-Stage2 |
1.489410E-01 |
| Stage1-vs-Stage3 |
1.242780E-04 |
| Stage1-vs-Stage4 |
2.992400E-04 |
| Stage2-vs-Stage3 |
2.041800E-01 |
| Stage2-vs-Stage4 |
1.642380E-01 |
| Stage3-vs-Stage4 |
7.505200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.611940E-02 |
| Normal-vs-AfricanAmerican |
1.816390E-04 |
| Normal-vs-Asian |
8.089800E-01 |
| Caucasian-vs-AfricanAmerican |
2.797700E-02 |
| Caucasian-vs-Asian |
5.309800E-01 |
| AfricanAmerican-vs-Asian |
1.485810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.542500E-03 |
| Normal-vs-Female |
6.378000E-03 |
| Male-vs-Female |
7.307600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.538200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.114400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.297290E-03 |
| Normal-vs-Age(81-100Yrs) |
5.157900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.535200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.599200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.736800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.970200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.918100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.172190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.300000E-01 |
| Normal-vs-Grade 2 |
3.582800E-01 |
| Normal-vs-Grade 3 |
1.550460E-04 |
| Normal-vs-Grade 4 |
9.34859999968118E-07 |
| Grade 1-vs-Grade 2 |
4.273000E-01 |
| Grade 1-vs-Grade 3 |
1.851910E-02 |
| Grade 1-vs-Grade 4 |
1.980720E-03 |
| Grade 2-vs-Grade 3 |
1.811340E-04 |
| Grade 2-vs-Grade 4 |
4.84130000000249E-06 |
| Grade 3-vs-Grade 4 |
3.399700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.256400E-01 |
| Normal-vs-ccB subtype |
2.684200E-03 |
| ccA subtype-vs-ccB subtype |
5.405700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.117400E-03 |
| Normal-vs-N1 |
1.001900E-02 |
| N0-vs-N1 |
2.216400E-01 |
|
|
